Development Level

Tbio 17 | 10,625
Tchem 12 | 1,890
Tclin 6 | 602

Collection

Eligible Kinase Proteins 2 | 134

IMPC Term

preweaning lethality, complete... 3 | 633
decreased total body fat amoun... 2 | 186
embryonic lethality prior to t... 2 | 187
abnormal anxiety-related respo... 1 | 1
abnormal embryo size 1 | 112
abnormal forebrain development 1 | 18
abnormal gait 1 | 51
abnormal hindbrain development 1 | 24
abnormal midbrain development 1 | 22
abnormal neural tube closure 1 | 37
abnormal optic disc morphology 1 | 10
abnormal social/conspecific in... 1 | 3
abnormal spinal cord morpholog... 1 | 8
absent seminal vesicle 1 | 2
cardiovascular system phenotyp... 1 | 35
decreased body length 1 | 108
decreased body weight 1 | 174
decreased circulating glucose ... 1 | 121
decreased circulating insulin ... 1 | 75
decreased heart rate variabili... 1 | 11
decreased lean body mass 1 | 195
decreased prepulse inhibition 1 | 52
embryonic lethality prior to o... 1 | 148
female infertility 1 | 34
increased circulating HDL chol... 1 | 63
increased circulating choleste... 1 | 53
increased circulating sodium l... 1 | 71
increased exploration in new e... 1 | 56
increased grip strength 1 | 83
increased lean body mass 1 | 107
increased or absent threshold ... 1 | 128
increased total body fat amoun... 1 | 57
male infertility 1 | 62
preweaning lethality, incomple... 1 | 260
short tibia 1 | 82
shortened RR interval 1 | 19

Disease

psoriasis 18 | 6,685
ovarian cancer 17 | 8,484
lung cancer 15 | 4,466
lung carcinoma 15 | 2,844
Cancer 14 | 2,346
glioblastoma 14 | 5,572
invasive ductal carcinoma 13 | 2,950
non-small cell lung cancer 13 | 2,798
Alzheimer's disease 12 | 644
lung adenocarcinoma 12 | 2,713
malignant mesothelioma 12 | 3,162
medulloblastoma, large-cell 12 | 6,234
osteosarcoma 12 | 7,933
tuberculosis 11 | 1,557
ulcerative colitis 11 | 2,087
astrocytoma 10 | 1,493
intraductal papillary-mucinous adenoma (IPMA) 10 | 2,956
pancreatic cancer 10 | 2,300
pancreatic ductal adenocarcinoma liver metastasis 10 | 1,795
pilocytic astrocytoma 10 | 3,086
primitive neuroectodermal tumor 10 | 3,031
Down syndrome 9 | 548
juvenile dermatomyositis 9 | 1,189
Brain Ischemia 8 | 87
Toxic encephalopathy 8 | 131
Vascular disease 8 | 281
dermatomyositis 8 | 933
interstitial cystitis 8 | 2,299
intraductal papillary-mucinous carcinoma (IPMC) 8 | 2,988
intraductal papillary-mucinous neoplasm (IPMN) 8 | 3,289
oligodendroglioma 8 | 2,849
subependymal giant cell astrocytoma 8 | 2,287
Meningitis 7 | 46
Multiple myeloma 7 | 1,327
Parkinson's disease 7 | 364
Prostatic Neoplasms 7 | 471
Rheumatoid Arthritis 7 | 1,160
atypical teratoid / rhabdoid tumor 7 | 4,369
cutaneous lupus erythematosus 7 | 1,056
diabetes mellitus 7 | 1,663
pediatric high grade glioma 7 | 2,712
Arthritis 6 | 248
Kidney disease 6 | 396
Obesity 6 | 616
Stomach Neoplasms 6 | 282
acute quadriplegic myopathy 6 | 1,157
adrenocortical carcinoma 6 | 1,427
colon cancer 6 | 1,475
cystic fibrosis 6 | 1,665
Asthma 5 | 349
Brain disease 5 | 83
Breast cancer 5 | 3,094
Carcinoma 5 | 2,147
Cardiomyopathies 5 | 90
Drug-Induced Liver Injury 5 | 118
Duchenne muscular dystrophy 5 | 602
Heart disease 5 | 279
Hyperalgesia 5 | 71
Hypersensitivity reaction type II disease 5 | 235
Immunologic Deficiency Syndromes 5 | 16
Inflammation 5 | 109
Multiple Sclerosis 5 | 498
Myocardial Infarction 5 | 126
Reperfusion Injury 5 | 84
breast carcinoma 5 | 1,614
gastric carcinoma 5 | 832
group 3 medulloblastoma 5 | 2,254
posterior fossa group A ependymoma 5 | 1,511
Anemia 4 | 252
Atherosclerosis 4 | 275
Dementia 4 | 129
Dermatitis 4 | 107
Diabetes Mellitus, Experimental 4 | 106
Endometriosis 4 | 535
Hypotension 4 | 53
IGA Glomerulonephritis 4 | 454
Ischemia 4 | 27
Liver disease 4 | 219
Lung Neoplasms 4 | 171
Lung disease 4 | 132
Mammary Neoplasms 4 | 410
Myocardial Ischemia 4 | 169
Necrosis 4 | 51
Neoplasm Invasiveness 4 | 127
Neoplasm Metastasis 4 | 138
Nerve Degeneration 4 | 73
Pick disease 4 | 1,893
Waldenstrons macroglobulinemia 4 | 765
autosomal dominant Emery-Dreifuss muscular dystrophy 4 | 499
ductal carcinoma in situ 4 | 1,745
ependymoma 4 | 2,514
esophageal adenocarcinoma 4 | 737
glioblastoma multiforme 4 | 347
medulloblastoma 4 | 1,524
ovarian neoplasm 4 | 97
pituitary cancer 4 | 1,972
primary Sjogren syndrome 4 | 789
primary pancreatic ductal adenocarcinoma 4 | 1,271
sarcoidosis 4 | 358
sonic hedgehog group medulloblastoma 4 | 1,482

Tissue

Blood and immune system 35 | 17,995
Cardiovascular System 34 | 17,958
Digestive Tract 34 | 18,473
Endocrine System 34 | 18,512
Female tissues 34 | 18,647
Liver and Pancreas 34 | 18,136
Male tissues 34 | 17,969
Nervous System 34 | 18,561
Respiratory system 34 | 17,484
Urinary Tract 34 | 18,444
Skin and soft tissues 33 | 18,115

Target Family

Non-IDG 23 | 11,971
Kinase 8 | 634
Enzyme 2 | 4,146
Transcription Factor 2 | 1,400

KEGG Pathway

Prion diseases 35 | 35
Metabolic pathways 1,254 | 1,254
Olfactory transduction 412 | 412
Pathways in cancer 402 | 402
HTLV-I infection 339 | 339
PI3K-Akt signaling pathway 338 | 338
Endocytosis 326 | 326
Epstein-Barr virus infection 279 | 279
Neuroactive ligand-receptor in... 276 | 276
Cytokine-cytokine receptor int... 262 | 262
Herpes simplex infection 262 | 262
MAPK signaling pathway 255 | 255
Viral carcinogenesis 253 | 253
Phagosome 231 | 231
Cell adhesion molecules (CAMs) 225 | 225
Ras signaling pathway 225 | 225
Rap1 signaling pathway 213 | 213
Regulation of actin cytoskelet... 213 | 213
Proteoglycans in cancer 202 | 202
cAMP signaling pathway 201 | 201
Focal adhesion 200 | 200
Natural killer cell mediated c... 199 | 199
Huntington's disease 194 | 194
Tuberculosis 187 | 187
Influenza A 184 | 184
Chemokine signaling pathway 182 | 182
Calcium signaling pathway 181 | 181
Axon guidance 176 | 176
Purine metabolism 171 | 171
Alzheimer's disease 169 | 169
Tight junction 169 | 169
NOD-like receptor signaling pa... 168 | 168
Protein processing in endoplas... 165 | 165
Transcriptional misregulation ... 165 | 165
cGMP-PKG signaling pathway 165 | 165
RNA transport 164 | 164
Oxytocin signaling pathway 158 | 158
Jak-STAT signaling pathway 157 | 157
Antigen processing and present... 156 | 156
Hippo signaling pathway 154 | 154
mTOR signaling pathway 153 | 153
Non-alcoholic fatty liver dise... 151 | 151
Adrenergic signaling in cardio... 150 | 150
MicroRNAs in cancer 150 | 150
Breast cancer 146 | 146
Alcoholism 145 | 145
Hepatitis B 145 | 145
Phospholipase D signaling path... 145 | 145
Parkinson's disease 142 | 142
Wnt signaling pathway 142 | 142
Signaling pathways regulating ... 141 | 141
Apoptosis 140 | 140
Insulin signaling pathway 138 | 138
Ubiquitin mediated proteolysis 137 | 137
Viral myocarditis 137 | 137
Measles 135 | 135
Ribosome 134 | 134
Oxidative phosphorylation 133 | 133
FoxO signaling pathway 132 | 132
Hepatitis C 132 | 132
Spliceosome 132 | 132
Dopaminergic synapse 131 | 131
Osteoclast differentiation 131 | 131
Autoimmune thyroid disease 130 | 130
Toxoplasmosis 130 | 130
Cell cycle 125 | 125
Platelet activation 124 | 124
AMPK signaling pathway 123 | 123
Lysosome 123 | 123
Type I diabetes mellitus 122 | 122
Vascular smooth muscle contrac... 121 | 121
Graft-versus-host disease 120 | 120
Sphingolipid signaling pathway 120 | 120
Neurotrophin signaling pathway 119 | 119
Oocyte meiosis 119 | 119
Th17 cell differentiation 119 | 119
Thyroid hormone signaling path... 118 | 118
Allograft rejection 116 | 116
Glutamatergic synapse 116 | 116
Leukocyte transendothelial mig... 116 | 116
Carbon metabolism 114 | 114
Serotonergic synapse 114 | 114
Cholinergic synapse 110 | 110
TNF signaling pathway 110 | 110
Insulin resistance 109 | 109
Hematopoietic cell lineage 108 | 108
Systemic lupus erythematosus 108 | 108
Chagas disease (American trypa... 106 | 106
T cell receptor signaling path... 104 | 104
Th1 and Th2 cell differentiati... 104 | 104
Glucagon signaling pathway 103 | 103
HIF-1 signaling pathway 103 | 103
Toll-like receptor signaling p... 103 | 103
Melanogenesis 102 | 102
Pyrimidine metabolism 102 | 102
AGE-RAGE signaling pathway in ... 101 | 101
Endocrine resistance 101 | 101
Estrogen signaling pathway 101 | 101
Retrograde endocannabinoid sig... 101 | 101
Amoebiasis 100 | 100
Rheumatoid arthritis 100 | 100

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Interleukin-1 beta IL1B Tclin Non-IDG -4.34333 22444.2 1345
Complement component C9 C9 Tbio Non-IDG -1.85517 71.0 229
Complement C1q subcomponent subunit C C1QC Tbio Non-IDG -1.27032 17.5 141
Complement C1q subcomponent subunit B C1QB Tbio Non-IDG -1.63026 41.3 161
Complement C1q subcomponent subunit A C1QA Tbio Non-IDG -1.71898 50.3 208
78 kDa glucose-regulated protein HSPA5 Tchem Non-IDG -3.28487 2003.3 918
Complement component C6 C6 Tbio Non-IDG -1.53803 35.0 124
Laminin subunit gamma-1 LAMC1 Tchem Non-IDG -1.73437 53.6 239
Dual specificity mitogen-activated protein kinase kinase 2 MAP2K2 Tclin Kinase -1.78634 57.0 688
C-C motif chemokine 5 CCL5 Tchem Non-IDG -3.34675 2314.5 487